Table 1.
Clinical Characteristics, DCE Parameters, and Pathological Outcomes of the 45 Patients with Prostate Cancer.
| Variables | |
|---|---|
| Clinical parameters | |
| Age (years) | 66.000 (63.000–71.000) |
| PSA at diagnosis (ng/mL) | 14.180 (9.075–20.895) |
| PSA density (ng/mL/mL) | 0.414 (0.216–0.660) |
| Positive biopsy core (%) | 33.333 (8.330–50.000) |
| DCE parameters | |
| Ktrans-min (min−1) | 4.000 (2.000–7.000) |
| Ktrans-median (min−1) | 19.000 (13.500–28.000) |
| Ktrans-max (min−1) | 55.000 (34.500–78.000) |
| kep-min (min−1) | 2.000 (1.500–4.000) |
| kep-median (min−1) | 13.000 (9.250–14.000) |
| kep-max (min−1) | 25.000 (20.000–33.000) |
| IAUC-min (mM·s) | 39.000 (19.500–60.500) |
| IAUC-median (mM·s) | 137.000 (114.000–191.500) |
| IAUC-max (mM·s) | 286.000 (210.500–411.000) |
| Outcomes from radical prostatectomy specimens | |
| ISUP risk group | |
| Low risk (I–II) | 22 (48.889%) |
| High risk (III–V) | 23 (51.111%) |
| Surgical margins | |
| Positive | 15 (33.333%) |
| Negative | 30 (66.667%) |
Continuous variables are expressed as the median and interquartile range (IQR). Categorical variables are expressed as counts (%). DCE: dynamic contrast-enhanced; ISUP: International Society of Urological Pathology; max: maximum; min: minimum; mL: millimeter; mM: millimolar; ng: nanogram; PSA: prostate-specific antigen; s: second.